Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenSante was a biotechnology company focused on the emerging field of nutrigenomics, providing personalized health and nutrition solutions based on genetic testing. The company developed diagnostic tools to identify genetic variations that influence how individuals metabolize nutrients and respond to specific diets. By analyzing key biomarkers such as MTHFR and APOE, GenSante aimed to provide actionable insights for managing cardiovascular health and metabolic wellness. Their services were primarily marketed to healthcare providers and consumers seeking tailored nutritional interventions. Although the company was a pioneer in the personalized nutrition space, it is no longer actively operating under its original structure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneSante.